Cargando…

Correction to: Decitabine plus CLAG chemotherapy as a bridge to haploidentical transplantation in the setting of acute myeloid leukemia relapse after HLA-matched sibling transplantation: a case report

Detalles Bibliográficos
Autores principales: Jin, Mengqi, Hu, Yongxian, Wu, Wenjun, Luo, Yi, Tan, Yamin, Yu, Jian, Jin, Aiyun, Yang, Luxin, Huang, He, Wei, Guoqing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6532122/
https://www.ncbi.nlm.nih.gov/pubmed/31122200
http://dx.doi.org/10.1186/s12885-019-5626-0
_version_ 1783420943895363584
author Jin, Mengqi
Hu, Yongxian
Wu, Wenjun
Luo, Yi
Tan, Yamin
Yu, Jian
Jin, Aiyun
Yang, Luxin
Huang, He
Wei, Guoqing
author_facet Jin, Mengqi
Hu, Yongxian
Wu, Wenjun
Luo, Yi
Tan, Yamin
Yu, Jian
Jin, Aiyun
Yang, Luxin
Huang, He
Wei, Guoqing
author_sort Jin, Mengqi
collection PubMed
description
format Online
Article
Text
id pubmed-6532122
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-65321222019-05-28 Correction to: Decitabine plus CLAG chemotherapy as a bridge to haploidentical transplantation in the setting of acute myeloid leukemia relapse after HLA-matched sibling transplantation: a case report Jin, Mengqi Hu, Yongxian Wu, Wenjun Luo, Yi Tan, Yamin Yu, Jian Jin, Aiyun Yang, Luxin Huang, He Wei, Guoqing BMC Cancer Correction BioMed Central 2019-05-23 /pmc/articles/PMC6532122/ /pubmed/31122200 http://dx.doi.org/10.1186/s12885-019-5626-0 Text en © The Author(s). 2019 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Correction
Jin, Mengqi
Hu, Yongxian
Wu, Wenjun
Luo, Yi
Tan, Yamin
Yu, Jian
Jin, Aiyun
Yang, Luxin
Huang, He
Wei, Guoqing
Correction to: Decitabine plus CLAG chemotherapy as a bridge to haploidentical transplantation in the setting of acute myeloid leukemia relapse after HLA-matched sibling transplantation: a case report
title Correction to: Decitabine plus CLAG chemotherapy as a bridge to haploidentical transplantation in the setting of acute myeloid leukemia relapse after HLA-matched sibling transplantation: a case report
title_full Correction to: Decitabine plus CLAG chemotherapy as a bridge to haploidentical transplantation in the setting of acute myeloid leukemia relapse after HLA-matched sibling transplantation: a case report
title_fullStr Correction to: Decitabine plus CLAG chemotherapy as a bridge to haploidentical transplantation in the setting of acute myeloid leukemia relapse after HLA-matched sibling transplantation: a case report
title_full_unstemmed Correction to: Decitabine plus CLAG chemotherapy as a bridge to haploidentical transplantation in the setting of acute myeloid leukemia relapse after HLA-matched sibling transplantation: a case report
title_short Correction to: Decitabine plus CLAG chemotherapy as a bridge to haploidentical transplantation in the setting of acute myeloid leukemia relapse after HLA-matched sibling transplantation: a case report
title_sort correction to: decitabine plus clag chemotherapy as a bridge to haploidentical transplantation in the setting of acute myeloid leukemia relapse after hla-matched sibling transplantation: a case report
topic Correction
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6532122/
https://www.ncbi.nlm.nih.gov/pubmed/31122200
http://dx.doi.org/10.1186/s12885-019-5626-0
work_keys_str_mv AT jinmengqi correctiontodecitabineplusclagchemotherapyasabridgetohaploidenticaltransplantationinthesettingofacutemyeloidleukemiarelapseafterhlamatchedsiblingtransplantationacasereport
AT huyongxian correctiontodecitabineplusclagchemotherapyasabridgetohaploidenticaltransplantationinthesettingofacutemyeloidleukemiarelapseafterhlamatchedsiblingtransplantationacasereport
AT wuwenjun correctiontodecitabineplusclagchemotherapyasabridgetohaploidenticaltransplantationinthesettingofacutemyeloidleukemiarelapseafterhlamatchedsiblingtransplantationacasereport
AT luoyi correctiontodecitabineplusclagchemotherapyasabridgetohaploidenticaltransplantationinthesettingofacutemyeloidleukemiarelapseafterhlamatchedsiblingtransplantationacasereport
AT tanyamin correctiontodecitabineplusclagchemotherapyasabridgetohaploidenticaltransplantationinthesettingofacutemyeloidleukemiarelapseafterhlamatchedsiblingtransplantationacasereport
AT yujian correctiontodecitabineplusclagchemotherapyasabridgetohaploidenticaltransplantationinthesettingofacutemyeloidleukemiarelapseafterhlamatchedsiblingtransplantationacasereport
AT jinaiyun correctiontodecitabineplusclagchemotherapyasabridgetohaploidenticaltransplantationinthesettingofacutemyeloidleukemiarelapseafterhlamatchedsiblingtransplantationacasereport
AT yangluxin correctiontodecitabineplusclagchemotherapyasabridgetohaploidenticaltransplantationinthesettingofacutemyeloidleukemiarelapseafterhlamatchedsiblingtransplantationacasereport
AT huanghe correctiontodecitabineplusclagchemotherapyasabridgetohaploidenticaltransplantationinthesettingofacutemyeloidleukemiarelapseafterhlamatchedsiblingtransplantationacasereport
AT weiguoqing correctiontodecitabineplusclagchemotherapyasabridgetohaploidenticaltransplantationinthesettingofacutemyeloidleukemiarelapseafterhlamatchedsiblingtransplantationacasereport